News

World’s most populous country gains access to Medtronic’s newest TAVR valve

Medtronic developed the self-expanding Evolut FX+ TAVR system with improved coronary access in mind. The FDA-approved device has now officially launched in India.

Joan Michaels, RN, director of the American College of Cardiology (ACC) National Cardiovascular Data Registry (NCDR) Transcatheter Valve Therapies (TVT) and IMPACT congenital heart registries, said the addition of the ambulatory surgical center (ASC) registry comes at a time when hospitals are expanding structural heart programs and ASC's will likely play a growing role to help free up more hospital cath labs for the more complex cases.

New registry helps hospitals expand outpatient services for heart patients

The initiation of the ACC Ambulatory Surgical Center Registry comes at a time when hospitals are expanding their structural heart programs. The registry is providing valuable details about which patients should stay at the hospital and which can be treated in an outpatient setting.

FDA highlights risks of evaluating blood pressure with unauthorized medical devices

The agency emphasized that many over-the-counter technologies marketed for this purpose have not been properly evaluated.

Healthcare AI today: Another angle on AI regulation, move fast but don’t break things, WISeR in the real world, more

Getting healthcare AI to fulfill its destiny—can we call it that now?—will require ‘scenario-based’ consideration of every use case.

CIVIE CEO Previews Major Announcement: ‘We See AI Giving Radiologists Complete Control Over Their Work-Life Balance’

Many if not most healthcare AI vendors market tweaked versions of large language models developed by other, usually larger companies. The lack of originality isn’t just a superficial concern. It may burden adopting healthcare organizations with practical, clinical and even legal risks. For clients of the radiology technology company CIVIE, formerly known as Collaborative Imaging, those worries are soon to be things of the past.

Repeat imaging rates higher when scans are interpreted by nurse practitioners, physician assistants

The finding is based on an analysis of nearly 1.4 million office-based imaging claims, conducted by the Harvey L. Neiman Health Policy Institute.

prior authorization claim deny denial insurance insurer payer Medicare Advantage

Members of Congress condemn Medicare model targeting ‘wasteful’ interventional radiology services

“It is not an exaggeration to say that the requirement of prior authorization for traditional Medicare services will kill seniors,” says Rep. Mark Pocan, D-Wis.

Referrers frequently failing to recommend patients for key interventional radiology procedure

An analysis of nearly 272,000 uterine fibroid healthcare encounters shows that only about 4% of women underwent uterine fibroid embolization, a minimally invasive IR treatment option.

Medtronic Symplicity Spyral renal denervation

Medtronic’s RDN system approved in Japan

Hypertension is a significant issue in Japan, impacting an estimated 43 million adults. Medtronic's Symplicity Spyral RDN system is now approved for the treatment of those patients.

leg veins chronic venous disease PAD peripheral artery disease

Drug-coated balloons make little impact on PAD outcomes

Researchers tracked data from more than 3,000 patients, calling for more clinical trials of antiproliferative agents other than paclitaxel.

Late-stage prostate cancer diagnoses on the rise

Experts say these new findings highlight the need for more effective screening initiatives among men who may face access barriers.

Biosense Webster, part of Johnson & Johnson MedTech, shared updated data on its Varipulse pulsed field ablation (PFA) system at AF Symposium 2024 in Boston,

Johnson & Johnson’s PFA platform is both safe and effective, real-world data confirm

The Varipulse PFA platform, which has already received FDA and CE mark approval, was linked to an adverse event rate of just 0.6%.

Around the web

Cardiovascular Business

World’s most populous country gains access to Medtronic’s newest TAVR valve

Medtronic developed the self-expanding Evolut FX+ TAVR system with improved coronary access in mind. The FDA-approved device has now officially launched in India.

Cardiovascular Business

New registry helps hospitals expand outpatient services for heart patients

Cardiovascular Business

FDA highlights risks of evaluating blood pressure with unauthorized medical devices

The agency emphasized that many over-the-counter technologies marketed for this purpose have not been properly evaluated.